Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 109Neoplasms 108Lung Neoplasms 66Prostatic Neoplasms 57Colorectal Neoplasms 48Carcinoma, Non-Small-Cell Lung 44Pancreatic Neoplasms 31Hematologic Neoplasms 28Multiple Myeloma 23Leukemia, Myeloid, Acute 23Stomach Neoplasms 21Ovarian Neoplasms 21Carcinoma, Hepatocellular 21Brain Neoplasms 21Lymphoma 20Melanoma 19Esophageal Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Disease 18Urinary Bladder Neoplasms 17Colonic Neoplasms 16Uterine Cervical Neoplasms 15Liver Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Head and Neck Neoplasms 14Endometrial Neoplasms 14Lymphoma, Non-Hodgkin 13Leukemia 13Kidney Neoplasms 13Carcinoma, Renal Cell 13

Interventions

trastuzumab deruxtecan 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Drug-Related Side Effects and Adverse Reactions × 30 days × Clear all
NCT07008027 2026-05-22

Real World Asparaginase Therapy Toxicity

St. Jude Children's Research Hospital

Not yet recruiting
200 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

NCT07582887 2026-05-13

Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental

Recruiting
70 enrolled
Breast

Breast Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡